A composite immune-nutritional and tumor marker score predicts outcomes in LA-ESCC treated with neoadjuvant chemoimmunotherapy and surgery.

Discov Oncol · 2026 · PMC12996501 · PMID 41670757

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The DFS and response between GINI, CYFRA211, FARI, and GCF in the external validation group Kaplan-Meier analysis of DFS revealed that both FARI ( p = 0.026) and GCF ( p = 0.017) effectively discriminated patients with poorer DFS outcomes, whereas GINI ( p = 0.548) and CYFRA211 ( p = 0.115) did not reach statistical significance (Fig.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.